Teva Pharmaceutical Industries Ltd. (TEVA) Friday said it launched an authorized generic of Actoplus Met, or pioglitazone/metformin tablets, in US.
Actoplus met is marketed by Takeda Pharmaceuticals U.S.A Inc. and used with diet and exercise to improve blood sugar control in adults with type 2 diabetes. Actoplus met had annual sales of about $413 million in the US, based on IMS sales data as of June 30, 2012.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.